Vitaeris Inc. is a startup based in Canada, 1 tracked investor.
Vitaeris Inc. is a company headquartered in Canada. Brouky records 1 investor associated with the company.
Vitaeris Inc. is a clinical-stage biotechnology company developing clazakizumab, an anti-interleukin-6 (IL-6) monoclonal antibody, aimed at treating chronic active antibody-mediated rejection in solid organ transplant patients and other chronic inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.